Pristautz H, Leb G, Raber J, Goebel R, Steinberger R, Borkenstein J
MMW Munch Med Wochenschr. 1980 Feb 8;122(6):199-202.
25 euthyroidal patients with elevated serum cholesterol levels were treated with 4 mg of D-thyroxine daily for 4 weeks; controls were made after this period and after a withdrawal period of another 4 weeks. At the end of the treatment period there was a significant decrease of the serum cholesterol level, of the basal and TRH-stimulated serum TSH and of the thyroidal radioiodine uptake. The radioimmunologically determined values of total T 3 and Free Thyroxine index and of the serum iodine level rose significantly without being accompanied by clinical hyperthyroid symptoms. These changes can be explained on one hand by the well known cholesterol lowering effect of D T-4 and by the inclusion of D-isomeres of thyroid hormones in the radioimmunoassay, and, on the other hand, by the fact that the above-mentioned medication causes an uptake of iodine, and, possibly, by a direct inhibitory effect of D T-4 on the pituitary gland.
25名甲状腺功能正常但血清胆固醇水平升高的患者,每天服用4毫克D-甲状腺素,持续4周;在此期间及之后又经过4周的停药期后进行对照。在治疗期结束时,血清胆固醇水平、基础及促甲状腺激素释放激素(TRH)刺激后的血清促甲状腺激素(TSH)以及甲状腺放射性碘摄取均显著下降。通过放射免疫法测定的总T3、游离甲状腺素指数及血清碘水平显著升高,且未伴有临床甲状腺功能亢进症状。这些变化一方面可由D-T4众所周知的降胆固醇作用以及放射免疫测定中包含甲状腺激素的D-异构体来解释,另一方面可由上述药物导致碘摄取这一事实来解释,并且可能还与D-T4对垂体的直接抑制作用有关。